New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
12:00 EDTRAI, PM, MO, CVS, LOCVS plans to stop selling cigarettes and other tobacco products
CVS Caremark (CVS) earlier today announced its decision to cease selling tobacco at all locations starting October 1. WHAT'S NOTABLE: CVS Caremark said its choice to exit the tobacco category does not affect the company's 2014 segment operating profit guidance, 2014 earnings per share guidance, or the company's five-year financial projections. The company estimates that it will lose approximately $2B in revenues on an annual basis from the tobacco shopper, equating to approximately 17c per share. Given the anticipated timing for implementation of this change, the impact to 2014 earnings per share is expected to be in the range of 6c-9c per share. The company has identified incremental opportunities that are expected to offset the profitability impact, CVS added. WHAT'S NOTABLE: Deutsche Bank believes CVS Caremark's decision to stop selling tobacco products is in-line with its strategy to become more of a healthcare services company. Deutsche thinks the move could improve CVS' competitive positioning and it keeps a Hold rating on the stock. PRICE ACTION: During late morning trading, shares of CVS Caremark were down 1.5% to trade near $65. Like the broader S&P 500, shares of a number of tobacco product makers were generally lower. Philip Morris (PM) fell 0.88% to $76.20, Reynolds American (RAI) fell 0.7% to $47.17, Lorillard (LO) fell 2.5% to $47.64 and Altria Group (MO) fell 1.2% to $34.02.
News For CVS;PM;LO;MO;RAI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 9, 2016
08:38 EDTCVSCVS Health expects to return more than $5B to shareholders in 2016
Subscribe for More Information
08:35 EDTCVSCVS Health expects Medicare Part D to maintain market share position in 2016
08:34 EDTCVSCVS Health expects Target Pharmacy integration to be completed by end of summer
Subscribe for More Information
08:33 EDTCVSCVS Health expects to complete majority of Omnicare integration by year end
Subscribe for More Information
08:32 EDTCVSCVS Health added 500K net lives in 2016 for SilverScript
Subscribe for More Information
06:55 EDTCVSCVS Health backs Q1 adjusted EPS view of $1.14-$1.17
Subscribe for More Information
06:53 EDTCVSCVS Health reports Q4 pharmacy same store prescription volumes up 5%
06:53 EDTCVSCVS Health reports Q4 SSS up 3.5%
Subscribe for More Information
06:52 EDTCVSCVS Health reports Q4 adjusted EPS $1.53, consensus $1.53
Reports Q4 revenue $41.15B, consensus $4.18B.
February 8, 2016
14:28 EDTCVSNotable companies reporting before tomorrow's open
Subscribe for More Information
07:58 EDTCVSCVS Health volatility elevated into Q4 and outlook
Subscribe for More Information
07:39 EDTMODiverse set of companies planning layoffs, pulling back spending, WSJ says
Subscribe for More Information
February 4, 2016
09:18 EDTPMOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Glu Mobile (GLUU), up 21.9%... Solaredge Technologies (SEDG), up 11.2%... Cadence Design (CDNS), up 6.6%. ALSO HIGHER: VirnetX Holding (VHC), up 91.7% after the company won a $625.6M verdict in favor of in a patent infringement lawsuit against Apple (AAPL)... Viacom (VIAB), up 5.1% after CNBC's David Faber reported that sources said CEO Philippe Dauman is likely to be named Chairman despite objections from Shari Redstone. DOWN AFTER EARNINGS: GoPro (GPRO), down 16.4%... ConocoPhillips (COP), down 2.9%... Dunkin Brands (DNKN), down 2.1%... Philip Morris (PM), down 3.2%. ALSO LOWER: L Brands (LB), down 3.3% after providing Q4 guidance, reporting January Same-Store Sales were down 2%... MannKind (MNKD), down 8.1% after Piper Jaffray analyst Joshua Schimmer calls the company a penny stock with a mid-cap valuation.
07:03 EDTPMPhilip Morris sees FY16 EPS $4.25-$4.35, consensus $4.52
Excluding an unfavorable currency impact, at prevailing exchange rates, of approximately $0.60 for the full-year 2016, the reported diluted earnings per share range represents a projected increase of approximately 10% to 12% versus adjusted diluted earnings per share of $4.42 in 2015. This forecast does not include any share repurchases in 2016. The company will revisit the potential for repurchases as the year unfolds, depending on the currency environment. Estimates 2016 international cigarette volume, excluding the People's Republic of China and the U.S., to decline by approximately 2.0%-2.5%, in line with the estimated decline of 2.4% in 2015. CEO Andre Calantzopoulos said, "We enter 2016 with enhanced business fundamentals and ongoing strategic initiatives that will strengthen them further. While currency headwinds endure, we fully expect to continue to grow our business and generously reward our shareholders."
07:01 EDTPMPhilip Morris reports Q4 adjusted EPS 81c, consensus 81c
Subscribe for More Information
February 3, 2016
14:48 EDTPMNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Philip Morris (PM), consensus 81c... AstraZeneca (AZN), consensus 88c... Occidental Petroleum (OXY), consensus (12c)... ConocoPhillips (COP), consensus (65c)... Cigna (CI), consensus $1.80... Intercontinental Exchange (ICE), consensus $3.01... Boston Scientific (BSX), consensus 25c... Charter Communications (CHTR), consensus (12c)... Ralph Lauren (RL), consensus $2.13... Dunkin' Brands (DNKN), consensus 50c... GrubHub (GRUB), consensus 14c... Level 3 (LVLT), consensus 53c... AmerisourceBergen (ABC), consensus $1.25... Cummins (CMI), consensus $2.11.
13:07 EDTPMPhilip Morris technical comments before earnings
The shares are trading near the 52-week high of $90.31 ahead of earnings. The $90 level has been resistance for the shares since the summer of 2013. If there is a breakout above $90 on strong news, next resistance would be at $91.63, $92.92, and $95.68. If the news is bearish, the $90 area is likely to remain as major resistance. Support levels to watch below $90 as potential downside objectives are at $88.06, $85.83, and $83.44.
09:32 EDTCVSCVS Health initiated with an Overweight at Atlantic Equities
Target $114.
February 1, 2016
13:20 EDTCVSCVS Health to make overdose-reversing drug available without prescription in OH
Subscribe for More Information
10:51 EDTCVSActive calls; INTC CVS TWTR APC BAC
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use